Cited 0 times in Scipus Cited Count

Therapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?

DC Field Value Language
dc.contributor.authorLim, YC-
dc.contributor.authorLee, JS-
dc.contributor.authorChoi, EC-
dc.date.accessioned2010-12-14T01:57:20Z-
dc.date.available2010-12-14T01:57:20Z-
dc.date.issued2009-
dc.identifier.issn0001-6489-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/549-
dc.description.abstractCONCLUSIONS: Our study suggests that routine level I dissection may not be necessary in the surgical management of clinically N + hypopharyngeal squamous cell carcinoma (SCC) in patients who do not have a positive lymph node in neck level I.



OBJECTIVE: To determine whether level I lymph node dissection can be saved in patients with clinically N + hypopharyngeal SCC.



PATIENTS AND METHODS: Retrospective analysis of 64 consecutive clinically N + patients with untreated hypopharyngeal SCC between 1994 and 2006. Forty-seven patients underwent level I lymph node dissection and the remaining 17 did not. Forty-five of the 64 patients were followed for a minimum of 2 years, if alive, or until death. Of these 45 patients, 35 underwent ipsilateral level I dissection of the neck.



RESULTS: The incidence of occult metastases to level I was 6% (3 of 47). Six (17%) of 35 patients with level I dissection and 1 (10%) of 10 patients without level I dissection experienced regional recurrence (p>0.05). The 2-year disease-specific survival in 47 patients undergoing level I neck dissection was 44% compared with 37% in 17 patients who did not undergo level I neck dissection (p>0.05).
-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCarcinoma, Squamous Cell-
dc.subject.MESHCombined Modality Therapy-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHHumans-
dc.subject.MESHHypopharyngeal Neoplasms-
dc.subject.MESHKaplan-Meier Estimate-
dc.subject.MESHLymph Nodes-
dc.subject.MESHLymphatic Metastasis-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNeck Dissection-
dc.subject.MESHNeoplasm Recurrence, Local-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHRadiotherapy, Adjuvant-
dc.titleTherapeutic selective neck dissection (level II-V) for node-positive hypopharyngeal carcinoma: is it oncologically safe?-
dc.typeArticle-
dc.identifier.pmid18607981-
dc.identifier.urlhttp://informahealthcare.com/doi/abs/10.1080/00016480802001483-
dc.contributor.affiliatedAuthor이, 진석-
dc.type.localJournal Papers-
dc.identifier.doi10.1080/00016480802001483-
dc.citation.titleActa oto-laryngologica-
dc.citation.volume129-
dc.citation.number1-
dc.citation.date2009-
dc.citation.startPage57-
dc.citation.endPage61-
dc.identifier.bibliographicCitationActa oto-laryngologica, 129(1). : 57-61, 2009-
dc.identifier.eissn1651-2251-
dc.relation.journalidJ000016489-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse